Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases

N Sgherza, P Curci, R Rizzi, O Battisti, A Perfetto… - Annals of …, 2024 - Springer
COVID-19-related mortality in the onco-hematological setting is higher than in general
population, and patients with multiple myeloma (MM) have been reported to be particularly …
被引用次数：2 相关文章

Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases.

N Sgherza, P Curci, R Rizzi, O Battisti… - Annals of …, 2023 - europepmc.org
Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more
anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases. - Abstract - Europe …

Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases

N Sgherza, P Curci, R Rizzi, O Battisti… - Annals of …, 2024 - pubmed.ncbi.nlm.nih.gov
Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more
anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases Clinical outcome of …